Immunic Stock Jumps After Pricing $400 Million Private Placement

Immunic Inc (NASDAQ:IMUX) is surging Friday after the late‑stage biotech announced a private placement of up to $400 million.Immunic stock is gaining positive traction. Why are IMUX shares climbing?A Look At The DealThe financing was led by existing investor BVF Partners and included a strong lineup of institutional backers such as OrbiMed, RA Capital, Janus Henderson, Avidity Partners and EcoR1 Capital.The structure provides $200 million upfront through pre‑funded warrants priced at 87 cents each, with the ...